clinical trials | Neurology Associates

top of page

Jan 18, 20232 min read

Lecanemab Has FDA Approval, But Alzheimer’s Patients Should Proceed With Caution

Neurology Associates Neuroscience Center looks at the side effects of lecanemab, the newly FDA-approved drug for Alzheimer's.

bottom of page